These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 17646396)

  • 1. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway.
    Lamouille S; Derynck R
    J Cell Biol; 2007 Jul; 178(3):437-51. PubMed ID: 17646396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming Growth Factor β1-induced Apoptosis in Podocytes via the Extracellular Signal-regulated Kinase-Mammalian Target of Rapamycin Complex 1-NADPH Oxidase 4 Axis.
    Das R; Xu S; Nguyen TT; Quan X; Choi SK; Kim SJ; Lee EY; Cha SK; Park KS
    J Biol Chem; 2015 Dec; 290(52):30830-42. PubMed ID: 26565025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells.
    Cheng K; Hao M
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
    Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
    Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion.
    Lamouille S; Connolly E; Smyth JW; Akhurst RJ; Derynck R
    J Cell Sci; 2012 Mar; 125(Pt 5):1259-73. PubMed ID: 22399812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.
    Galliher AJ; Schiemann WP
    Breast Cancer Res; 2006; 8(4):R42. PubMed ID: 16859511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation.
    Song K; Wang H; Krebs TL; Danielpour D
    EMBO J; 2006 Jan; 25(1):58-69. PubMed ID: 16362038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation.
    Galbaugh T; Cerrito MG; Jose CC; Cutler ML
    BMC Cell Biol; 2006 Sep; 7():34. PubMed ID: 16984645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II.
    Maeda M; Shintani Y; Wheelock MJ; Johnson KR
    J Biol Chem; 2006 Jan; 281(1):59-68. PubMed ID: 16267045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
    Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β2 induces epithelial-mesenchymal transition in cultured human lens epithelial cells through activation of the PI3K/Akt/mTOR signaling pathway.
    Guo R; Meng Q; Guo H; Xiao L; Yang X; Cui Y; Huang Y
    Mol Med Rep; 2016 Feb; 13(2):1105-10. PubMed ID: 26647778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
    Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
    Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Novel mTOR Complex 1/2 Inhibitor P529 Inhibits Human Lung Myofibroblast Differentiation.
    Ferguson KT; Torr EE; Bernau K; Leet J; Sherris D; Sandbo N
    J Cell Biochem; 2017 Aug; 118(8):2241-2249. PubMed ID: 28078713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.
    Bhowmick NA; Zent R; Ghiassi M; McDonnell M; Moses HL
    J Biol Chem; 2001 Dec; 276(50):46707-13. PubMed ID: 11590169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
    Kim SH; Yu HS; Park HG; Ha K; Kim YS; Shin SY; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():73-82. PubMed ID: 23643758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.